Phase III trial of Alzheimer’s drug offers hope to patients...
Scientists have completed the first phase III clinical trial of a drug that targets a tau, the hallmark protein of Alzheimer’s the forms twisted fibers and neuron death....
read moreLearningRx1
Scientists have completed the first phase III clinical trial of a drug that targets a tau, the hallmark protein of Alzheimer’s the forms twisted fibers and neuron death....
read more